ANI Pharmaceuticals, Inc.· ANIP
🇺🇸 US · SmallSP600NASDAQ
- Price
- $79.20
- Day
- -1.07%
- Mkt Cap
- $1.80B
- 52W Range
- $64.69 – $99.50
- Volume
- 289.5K
- Beta
- 0.43
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
PRINCETON, N. J. , July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August 7, 2026, at 8:00 a. m.
Read full article
Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for branded medicines and and key policy details remain unclear.
Read full article
Bessemer Group Inc. lifted its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) by 52.0% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 57,909 shares of the specialty pharmaceutical company's stock after purchasing an additional 19,800 shares during the quarter. Bessemer
Read full article
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Judge Sheldon K. Rennie, on July 16, 2026, denied ANI's post-trial motions for a new trial and judgment as a matter of law. ANI intends to appeal to the Delaware Supreme Court and continue to seek to recover the value of the assets it sold to CG Oncology under the 2010 Agreement between the parties.
Read full article